Search Results - Martin Pecherstorfer

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]

    Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments] by Heinz Ludwig, E. Fritz, Clemens Leitgeb, Martin Pecherstorfer, H. Samonigg, J. C. Schuster

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review

    Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review by Gernot Wagner, Hannah Karolina Stollenwerk, Irma Klerings, Martin Pecherstorfer, Gerald Gartlehner, Josef Singer

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]

    Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments] by Heinz Ludwig, E. Fritz, Clemens Leitgeb, Martin Pecherstorfer, H. Samonigg, J. C. Schuster

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices

    Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices by Henning W. Woitge, Martin Pecherstorfer, Yuming Li, Andrea Keck, Eva Horn, Reinhard Ziegler, Markus J. Seibel

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie... by Jean‐Jacques Body, Ingo Diel, M. Lichinitzer, A. F Lazarev, Martin Pecherstorfer, R. Bell, Debu Tripathy, B. Bergström

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.

    Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease. by Markus J. Seibel, Henning W. Woitge, Martin Pecherstorfer, M Karmatschek, Evelyn M. Horn, Heinz Ludwig, Franz Paul Armbruster, Robert F. Ziegler

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Bone Resorption in Multiple Myeloma and in Monoclonal Gammopathy of Undetermined Significance: Quantification by Urinary Pyridinium Cross-Links of Collagen

    Bone Resorption in Multiple Myeloma and in Monoclonal Gammopathy of Undetermined Significance: Quantification by Urinary Pyridinium Cross-Links of Collagen by Martin Pecherstorfer, Markus J. Seibel, Henning W. Woitge, Eva Horn, J. C. Schuster, Jane Neuda, P. Sagaster, H Köhn, Péter Bayer, D. Thiébaud, Heinz Ludwig

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    JunB is a key regulator of multiple myeloma bone marrow angiogenesis

    JunB is a key regulator of multiple myeloma bone marrow angiogenesis by Fengjuan Fan, Stefano Malvestiti, Sonia Vallet, Judith Lind, José Manuel García-Manteiga, Eugenio Morelli, Qinyue Jiang, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Andreas Stadlbauer, Chunyan Sun, Heng Mei, Martin Pecherstorfer, Latifa Bakiri, Erwin F. Wagner, Giovanni Tonon, Martin Sattler, Yu Hu, Pierfrancesco Tassone, Dirk Jaeger, Klaus Podar

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional study

    The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Aus... by Jakob M. Riedl, Florian Posch, Gerald W. Prager, Wolfgang Eisterer, Leopold Oehler, Thamer Sliwa, Klaus Wilthoner, Andreas Petzer, Petra Pichler, Eva Hubmann, Thomas Winder, Sonja Burgstaller, Markus Korger, Johannes Andel, Richard Greil, H Neumann, Martin Pecherstorfer, Kathrin Philipp‐Abbrederis, Angela Djanani, Birgit Gruenberger, Friedrich Laengle, Ewald Wöll, Armin Gerger

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

    Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study... by Stefan Kubicka, Richard Greil, Thierry André, Jaafar Bennouna, Javier Sastre, Eric Van Cutsem, Roger von Moos, Pia Österlund, Irmarie Reyes‐Rivera, Thomas Müller, Martina Makrutzki, Dirk Arnold, Johannes Andel, P Balcke, B. Benedicic, W. Eisterer, Michael Fridrik, Björn Jagdt, Felix Keil, A. Kretschmer, Peter Krippl, Horst Oexle, Martin Pecherstorfer, H. Samonigg, Matthias Schmid, J. Thaler, Christoph Tinchon, Hannah Weiss, Janine Arts, Marc De Man, G Demolin, Jos Janssens, Marc Polus, B. Benczikova, Bohuslav Melichar, Jana Prausová, Pavel Vítek, Fahimeh Andersen, Brita B. Jensen, Nina Keldsen, Kell Østerlind, Kirsten Vistisen, Anneli Elme, Agnes Mägi, Kristiina Ojamaa, R. Ristamäki, Tapio Salminen, Méher Ben Abdelghani, O. Bouché, Christophe Borg, Karine Bouhier‐Leporrier, G. Breysacher, Laurence Choné, M.-C. Clavero Fabri, G. Deplanque, Françoise Desseigne, L.-M. Dourthe, J. Ezenfis, R. Faroux, E. François, C Garnier, M Gaspard, Mohamed Hebbar, J.F. Illory, Marie‐Christine Kaminsky, Thierry Lecomte, J. Legoux, B. Levaché, Camille Lobry, JP Lotz, May Mabro, Sophie Manet-Lacombe, S. Manfredi, T. Matysiak Budnik, Laurent Miglianico, L. Mineur, Isabelle Moullet, H. Naman, P. Nouyrigat, Sandrine Oziel‐Taieb, H. Perrier, D. Pezet, Jennifer Philip, V. Pottier, M. Porneuf, M Ramdani, Daniel Ré, Y. Rinaldi, D. Spaeth, Julien Taı̈eb, E. Terrebonne, Patrick Texereau, Anne Thirot Bidault, C. Tournigand, N. Tubiana-Mathieu, J Vantelon, F. Viret, Marc Ychou, Markus Bangerter, Markus Bertram

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: